Clinical Trial Update: Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluate the combination of topotecan, paclitaxel, and filgrastim in patients with previously untreated extensive-stage small cell lung ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Filgrastim (filgrastim)
• PACLITAXEL (PACLITAXEL)
• Topotecan (topotecan)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED